Selih & Partners has advised ADM on investing in precision fermentation company Acies Bio. Solo practitioner Klemen Ticar advised Acies Bio on the deal.
ADM is a New York-listed multinational company, operating in food and commodities agricultural origination and processing. Acies Bio is a Slovenia-based biotechnology company specializing in R&D and manufacturing services for developing and scaling synthetic biology and precision fermentation technologies for food, agriculture, and industrial applications.
According to ADM, this investment will help it “more quickly advance projects in the field of precision microbial fermentation by leveraging Acies Bio’s extensive microbial capabilities and contract manufacturing services.” ADM’s investment in Acies Bio is being made through ADM Ventures, the company’s corporate venture capital arm.
The Selih & Partners team included Partners Natasa Pipan Nahtigal and Spela Remec, Legal Adviser Branko Milosevic, and Associates Miha Hocevar and Marusa Polak.
